Skip to main content
. 2013 May 1;40(5):050901. doi: 10.1118/1.4802733

Figure 9.

Figure 9

A patient with a 2.2 cm invasive breast cancer was imaged with MBI prior to initiation of neoadjuvant chemotherapy (panel a) and again at 3 weeks after initiation (panel b). MBI performed at 3 weeks showed nearly complete resolution of the tumor, indicating a functional response to neoadjuvant chemotherapy. Surgery performed after four months of therapy showed complete pathological response (pCR), i.e., no residual in situ or invasive disease.